🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Robert V. Rawson

The University of Sydney

ORCID: 0000-0003-0655-4963

Also affiliated with Royal Prince Alfred Hospital, Melanoma Institute Australia

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma”.

Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

Annals of Oncology(2020)10.1016/j.annonc.2020.07.016

N/A

0.538DataRank · unranked

35 citations

Chandra Mani Adhikari, Serigne Lo, Robert V. Rawson, Rodabe N. Amaria, Alexander M. Menzies +16 more

Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort

Annals of Oncology(2025)10.1016/j.annonc.2025.10.018

N/A

0.345DataRank · unranked

9 citations

Richard A. Scolyer, Elizabeth M. Burton, Klaus J. Busam, Kuang Yu Chen, Ashley Cimino‐Mathews +18 more

Representativeness of initial skin biopsies showing pure desmoplastic melanoma: implications for management

Pathology(2023)10.1016/j.pathol.2022.12.346

N/A

0.312DataRank · unranked

7 citations

I A Vergara, Jonathan R. Stretch, R.P.M. Saw, John F. Thompson, Serigne Lo +3 more